BMP-2 induces EMT and stemness of breast cancer cells through the Rb and CD44 signaling pathways, which act not only via Smad-dependent pathways but also via the PI3 kinase-Akt signaling pathway (Huang et al., 2017). The gene discussed is CD44; the disease is breast cancer.